Cargando…
Recombinant Thrombomodulin Used to Successfully Treat Cronkhite-Canada Syndrome with Disseminated Intravascular Coagulation due to Sepsis in a Compromised Patient
Cronkhite-Canada syndrome (CCS) is a rare non-inherited disease characterized by gastrointestinal polyposis, chronic diarrhea, ectodermal dysplasia, skin hyperpigmentation, hair loss and nail atrophy. Although the efficacy of corticosteroid and immunomodulatory agents has been demonstrated, no stand...
Autores principales: | Morino, Kahori, Honma, Yuichi, Kumei, Shinsuke, Watanabe, Tatsuyuki, Kume, Keiichiro, Yoshikawa, Ichiro, Harada, Masaru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society of Internal Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262703/ https://www.ncbi.nlm.nih.gov/pubmed/29877275 http://dx.doi.org/10.2169/internalmedicine.0633-17 |
Ejemplares similares
-
Efficacy of recombinant human soluble thrombomodulin in disseminated intravascular coagulation
por: Yasuda, T, et al.
Publicado: (2010) -
Adequate application of recombinant thrombomodulin for sepsis-associated disseminated intravascular coagulation
por: Iba, Toshiaki
Publicado: (2015) -
Thrombomodulin/activated protein C system in septic disseminated intravascular coagulation
por: Ikezoe, Takayuki
Publicado: (2015) -
Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments
por: Hayakawa, Mineji
Publicado: (2017) -
Effect of Thrombomodulin Alfa on Disseminated Intravascular Coagulation in Patients with Lung Cancer
por: Nakano, Kentaro, et al.
Publicado: (2017)